Anticancer immunotherapy
Learn more about how we developed a synthetic vaccine using a natural product and novel chemical linker as a potential anticancer therapy.
Where did we start?
One of the most exciting new therapies to emerge in the search for anticancer therapies is to train the human immune system to recognise aberrant cells.
What did we do?
Generated a synthetic vaccine from a highly immunogenic natural product utilising a new chemical linker.
What is the impact?
This research successfully demonstrated that a synthetic vaccine has potential as a human therapy and is being further refined in ongoing research.
Research team
mRNA and lipid nanoparticles team
Design and synthesis of vaccine adjuvants and ionisable lipids used in vaccines.
Related publications
Publications
No result found